Jay Evans | Chief Scientific and Strategy Officer

Jay Evans, Chief Scientific and Strategy Officer, Inimmune

Dr. Evans is the Chief Scientific and Strategy Officer and Cofounder of Inimmune Corp. Dr. Evans is also Director of the Center for Translational Medicine at the University of Montana and a Research Professor in the Division of Biological Sciences. He has over 20 years’ experience in the biotechnology and pharmaceutical industry including 15 years at GlaxoSmithKline Vaccines (formerly Corixa Corporation) where he held various roles including North American Pre-Clinical Innovation Team Leader, Project Leader, and Investigator. Dr. Evans completed his Postdoctoral Fellowship at the University of Texas Southwestern Medical Center and St. Jude Children’s Research Hospital working in HIV immunology, stem cell transplantation, and vector-based gene therapy systems. Dr. Evans holds a Ph.D. in Molecular and Cellular Biology from Oregon State University and a B.S. in Biology from Pacific Lutheran University.


Pre-Congress Workshops - Monday 28th October @ 14:00

Mucosal & Alternative Delivery Workshop [PM1]

Senior Representative, Intravacc 

Day 1 - Tuesday 29th October @ 15:45

Saponin Adjuvants: Challenges and Opportunities

Senior Representative, Desert King

Senior Representative, Amerstem

Day 2 - Wednesday 30th October @ 11:30

Challenges of universal flu & coronavirus vaccines

last published: 10/Jul/24 14:15 GMT

back to speakers